In the full analysis set, a nonsignificant trend toward improvement was noted; however, in the per‐protocol population, a significant improvement of 0.09 m/s was observed in the 350 mg group, approaching the clinically relevant threshold of 0.1 m/s.
← all excerpts
Pharmacological intervention: Challenges and promising outcomes for fat loss and preservation of lean body mass in the treatment of overweight and type 2 diabetes.
1
—
—